Home › Funds › Koss-Olinger Consulting, LLC › CATH

Koss-Olinger Consulting, LLC position in CATH

GLOBAL X FDS

Koss-Olinger Consulting, LLC reported holding 22,111 shares of CATH (GLOBAL X FDS) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.15% of its reported portfolio and ranking #27 among its reported holdings. Koss-Olinger Consulting, LLC has disclosed CATH holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)22.11K sh
Reported value held$2.01M
Portfolio Weight0.15%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Koss-Olinger Consulting, LLC's CATH position evolved

Koss-Olinger Consulting, LLC first disclosed a stake in CATH in Q3 2023 at 45,093 shares (US$2.4M). The position peaked in Q2 2024 at 45,093 shares, worth US$2.9M. Across 12 filings, Koss-Olinger Consulting, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 22,111 shares valued at US$2.0M. Notable position changes include a 28% trim in Q2 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 45.09K $2.36M New
Q4 2023 45.09K $2.62M Hold
Q2 2024 45.09K $2.95M New
Q3 2024 38.30K $2.66M Reduce
Q4 2024 36.09K $2.56M Reduce
Q1 2025 36.09K $2.44M Hold
Q2 2025 26.02K $1.96M Reduce
Q3 2025 26.02K $1.96M Hold
Q4 2025 22.04K $1.81M Reduce
Q1 2026 22.04K $1.72M Hold
Q2 2026 22.04K $1.95M Hold
Q3 2026 22.11K $2.01M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CATH and 13F data

CATH (GLOBAL X FDS) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in CATH — the largest reported positions include Fund Evaluation Group, LLC (US$87.1M), CENTRAL TRUST Co (US$42.4M), BCM ADVISORS, LLC (US$19.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CATH

All CATH fund holders →

FAQ

How long has Koss-Olinger Consulting, LLC held CATH?

Koss-Olinger Consulting, LLC has disclosed CATH holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Koss-Olinger Consulting, LLC's current position in CATH?

As of Q3 2026, Koss-Olinger Consulting, LLC holds 22.11K shares of CATH (GLOBAL X FDS), valued at $2.01M, representing 0.15% of its reported portfolio and ranking #27.

Has Koss-Olinger Consulting, LLC been buying or selling CATH?

In the latest 13F filing (Q3 2026), Koss-Olinger Consulting, LLC held unchanged its position in CATH. The position peaked in Q2 2024 at 45.09K shares.

Which other funds hold CATH?

Other major institutional holders of CATH include Fund Evaluation Group, LLC, CENTRAL TRUST Co, BCM ADVISORS, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.